Critical event management provider OnSolve stated on Wednesday that the public health authorities are using its CodeRED product to communicate with citizens and first responders regarding the COVID-19 vaccine availability and immunization logistics across the US.
The company has established a public advisory to help government officials at the local, state and federal levels, as well healthcare organizations, including hospitals, maximize their efforts to effectively and safely organize their COVID-19 vaccination effort.
Currently, nearly 200 communities are using the company's CodeRed to manage the sharing of information related to COVID-19 vaccine deployment and nearly 640,000 messages related to vaccine deployment have been sent. They are leveraging CodeRED's rapid, tailored critical communications capabilities and easy integration with other emergency management solutions for this vital public health project.
In conjunction, Coles County Health Department in Charleston, Illinois will use the company's CodeRED emergency notification solution to communicate critical information related to COVID-19 vaccine deployment in the area.
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB